John Overdeck’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $290K | Sell |
800
-6,800
| -89% | -$2.33M | ﹤0.01% | 4546 |
|
|
2026
Q1 | $2.67M | Sell |
7,600
-6,400
| -46% | -$2.28M | ﹤0.01% | 2544 |
|
|
2025
Q4 | $4.58M | Buy |
14,000
+13,000
| +1,300% | +$4.12M | 0.01% | 1792 |
|
|
2025
Q3 | $282K | Buy |
+1,000
| New | +$290K | ﹤0.01% | 3241 |
|
|
2022
Q1 | – | Sell |
-35,300
| Closed | -$7.94M | – | 2638 |
|
|
2021
Q4 | $7.94M | Sell |
35,300
-71,700
| -67% | -$15.1M | 0.02% | 918 |
|
|
2021
Q3 | $22.8M | Buy |
107,000
+80,900
| +310% | +$18.6M | 0.05% | 424 |
|
|
2021
Q2 | $6.36M | Buy |
26,100
+14,000
| +116% | +$3.44M | 0.01% | 1057 |
|
|
2021
Q1 | $3.01M | Sell |
12,100
-6,700
| -36% | -$1.6M | 0.01% | 1390 |
|
|
2020
Q4 | $4.32M | Buy |
18,800
+2,100
| +13% | +$484K | 0.01% | 1020 |
|
|
2020
Q3 | $4.24M | Buy |
16,700
+9,400
| +129% | +$2.33M | 0.02% | 877 |
|
|
2020
Q2 | $1.72M | Sell |
7,300
-10,400
| -59% | -$2.37M | 0.01% | 1174 |
|
|
2020
Q1 | $3.59M | Sell |
17,700
-10,600
| -37% | -$2.32M | 0.03% | 656 |
|
|
2019
Q4 | $6.82M | Sell |
28,300
-800
| -3% | -$176K | 0.02% | 779 |
|
|
2019
Q3 | $5.63M | Sell |
29,100
-25,000
| -46% | -$4.8M | 0.02% | 801 |
|
|
2019
Q2 | $9.97M | Buy |
54,100
+49,100
| +982% | +$8.79M | 0.03% | 603 |
|
|
2019
Q1 | $950K | Buy |
5,000
+2,000
| +67% | +$382K | ﹤0.01% | 1863 |
|
|
2018
Q4 | $584K | Sell |
3,000
-25,900
| -90% | -$5.05M | ﹤0.01% | 1997 |
|
|
2018
Q3 | $5.99M | Sell |
28,900
-207,700
| -88% | -$40.9M | 0.02% | 870 |
|
|
2018
Q2 | $43.7M | Buy |
236,600
+222,600
| +1,590% | +$39.4M | 0.13% | 202 |
|
|
2018
Q1 | $2.39M | Buy |
14,000
+3,000
| +27% | +$551K | 0.01% | 1400 |
|
|
2017
Q4 | $1.91M | Buy |
11,000
+3,000
| +38% | +$531K | 0.01% | 1505 |
|
|
2017
Q3 | $1.49M | Hold |
8,000
| – | – | 0.01% | 1475 |
|
|
2017
Q2 | $1.38M | Sell |
8,000
-9,900
| -55% | -$1.61M | 0.01% | 1690 |
|
|
2017
Q1 | $2.94M | Buy |
17,900
+10,900
| +156% | +$1.81M | 0.01% | 1215 |
|
|
2016
Q4 | $1.02M | Sell |
7,000
-4,000
| -36% | -$602K | ﹤0.01% | 1996 |
|
|
2016
Q3 | $1.83M | Buy |
11,000
+1,000
| +10% | +$169K | 0.01% | 1525 |
|
|
2016
Q2 | $1.52M | Buy |
10,000
+1,000
| +11% | +$155K | 0.01% | 1452 |
|
|
2016
Q1 | $1.35M | Sell |
9,000
-32,000
| -78% | -$4.75M | 0.01% | 1424 |
|
|
2015
Q4 | $6.66M | Buy |
41,000
+39,000
| +1,950% | +$6.13M | 0.03% | 574 |
|
|
2015
Q3 | $277K | Sell |
2,000
-10,000
| -83% | -$1.58M | ﹤0.01% | 1821 |
|
|
2015
Q2 | $1.84M | Buy |
12,000
+5,000
| +71% | +$801K | 0.01% | 1250 |
|
|
2015
Q1 | $1.12M | Buy |
+7,000
| New | +$1.1M | 0.01% | 1508 |
|
Other funds holding AMGN
John Overdeck's AMGN Position: Q2 2026 in Review
John Overdeck increased its Amgen (AMGN) stake by 1,475% in Q2 2026, buying an estimated $362M and bringing the position to 1,128,681 shares worth $409M. The position accounts for 0.3% of the portfolio, ranked #62.
John Overdeck first reported a position in AMGN in Q4 2013 and has held it in 47 quarters since. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- John Overdeck held 1,128,681 shares of Amgen worth $409M as of Q2 2026.
- John Overdeck bought 1,057,001 Amgen shares in Q2 2026, an estimated $362M.
- Amgen made up 0.3% of John Overdeck's portfolio in Q2 2026, its #62 holding.
- John Overdeck first reported a position in Amgen in Q4 2013 and has held it in 47 quarters since.
- 3,137 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.